DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS)
- Previous Close
18.58 - Open
18.50 - Bid 18.90 x --
- Ask 18.92 x --
- Day's Range
18.28 - 19.00 - 52 Week Range
11.92 - 23.26 - Volume
11,165,367 - Avg. Volume
8,506,532 - Market Cap (intraday)
21.547B - Beta (5Y Monthly) --
- PE Ratio (TTM)
22.00 - EPS (TTM)
0.86 - Earnings Date --
- Forward Dividend & Yield 0.62 (3.28%)
- Ex-Dividend Date Oct 23, 2024
- 1y Target Est
--
DaShenLin Pharmaceutical Group Co., Ltd. manufactures, wholesales, and retails pharmaceutical products in China. It provides Chinese and western patent medicines, ginseng tonic medicinal materials and Chinese herbal pieces, health care products, medical equipment, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China.
www.dslyy.comRecent News: 603233.SS
View MorePerformance Overview: 603233.SS
Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 603233.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 603233.SS
View MoreValuation Measures
Market Cap
21.55B
Enterprise Value
21.64B
Trailing P/E
22.00
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.80
Price/Book (mrq)
2.93
Enterprise Value/Revenue
0.81
Enterprise Value/EBITDA
14.51
Financial Highlights
Profitability and Income Statement
Profit Margin
3.45%
Return on Assets (ttm)
3.99%
Return on Equity (ttm)
12.20%
Revenue (ttm)
26.5B
Net Income Avi to Common (ttm)
914.75M
Diluted EPS (ttm)
0.86
Balance Sheet and Cash Flow
Total Cash (mrq)
6.74B
Total Debt/Equity (mrq)
79.16%
Levered Free Cash Flow (ttm)
2.47B